Kyoto, Japan

Keisuke Tazuru




Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2016-2019

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: The Innovative Journey of Keisuke Tazuru: A Pioneer in Glyco-Pharmaceuticals

Introduction: Keisuke Tazuru, based in Kyoto, Japan, is a prominent inventor known for his significant contributions to the field of glyco-pharmaceuticals. With a remarkable portfolio of six patents, Tazuru has been at the forefront of innovation in the biopharmaceutical industry, particularly in the development of glycosylated polypeptides and their therapeutic applications.

Latest Patents: Among his latest inventions are two notable patents that reflect his pioneering spirit. The first is titled "Glycosylated Polypeptide and Pharmaceutical Composition Containing Same." This invention focuses on providing a glycosylated polypeptide with a uniform sugar chain structure, which exhibits interferon β activity. The innovative method involves synthesizing a glycosylated peptide fragment along with at least two peptide fragments, then linking them together to create a potent therapeutic agent.

The second invention, "Sugar Chain-Polypeptide Complex," addresses the need for a product that can form a transparent and homogeneous hydrogel across a broad pH range. This complex is characterized by polypeptides with specific amino acid sequences where polar and nonpolar residues alternate, coupled with one or more sugar chains.

Career Highlights: Keisuke Tazuru's career is marked by his dedication to research and innovation at Glytech, Inc., where he applies his expertise in glyco-technology. His work not only advances scientific knowledge but also holds potential for developing effective therapeutic solutions for various medical conditions.

Collaborations: Throughout his career, Tazuru has collaborated with esteemed colleagues, including Hirofumi Ochiai and Taiji Shimoda. These partnerships enhance the collaborative spirit in research and push the boundaries of what is possible in glyco-pharmaceutical development.

Conclusion: Keisuke Tazuru stands out as a leading inventor in the field of glyco-pharmaceuticals. His innovative solutions, reflected in his patents, illustrate the potential of glycosylated compounds in medical applications. As he continues his work at Glytech, Inc., Tazuru's contributions will likely play a crucial role in the future of pharmaceutical therapies, improving patient outcomes and advancing healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…